Epigenomic and Epitranscriptomic Basis of Development and Human Disease

  • 20k

    Total Downloads

  • 70k

    Total Views and Downloads

About this Research Topic

Submission closed

Background

Gene expression is regulated genetically and epigenetically in accordance with the programmed developmental process starting from embryogenesis. Any aberrant micro-cytological or epigenetic events could cause devastating change in gene expression, leading to developmental abnormality this may lead to the initiation or the intensification of many diseases such as neurological disorders, cardiological diseases, cancers, and immunological disorders. The epigenetic mechanisms such as: dynamic modification of DNA and histone, nucleosome location, and noncoding RNA are all involved in the regulation of all the biological process. In addition to this base modifications in RNA have been identified to play a pivotal role as well.
Within the DNA base modifications in epigenome, methylation of 5-cytosine (5-mC) is believed to be the most abundant and best characterized epigenetic marker., At the same time, 5-hydroxycytosine (5-hmC), the sixth modified DNA base and the derivative of 5-mC, has also been characterized as an important epigenetic marker in mammalian epigenome. In contrast, studies on the N6-methyladenosine modification in DNA (6mdA) in mammals and insects requires more comprehension. On the other hand, N6-methyladenosine modification in RNA (m6A) has been acknowledged as the most abundant epitranscriptomic marker in mammals, and the extensive studies in recent years have made significant contribution to uncover the regulation mechanisms of this marker.

Functionally, epigenomic and epitranscriptomic markers continue to be highlighted to play an essential elemental role in embryogenesis, cell reprogramming, stem cell self-renewal, proliferation and differentiation, central nerve system (CNS), immune system development, aging, and so on. Furthermore, these modifications in DNA and RNA have been characterized at a biochemical, molecular, and phenotypical level including elucidation of their methyltransferase complexes (writers), demethylases (eraser), and direct interaction proteins (readers).
DNMTs serve as writers for 5-mC, while ten-eleven-translocation proteins (TETs) family including the three paralogs Tet1, Tet2 and Tet3 behave as the erasers for 5-mC, each harboring a catalytic core domain at the carboxyl terminal side. Tet1 catalyzes mainly the demethylation of promoters and transcription start sites and bears dual functions in tumoriogenesis and neuronal development. Tet2 primarily regulates the demethylation of enhancers and gene bodies, and inactivating mutations in the Tet2 gene account for almost 30% of all myeloid malignancies, while Tet3 has an essential role in embryonic development.
METTL3–METTL14 complex linked with WTAP and KIAA1429 has been characterized as main writers for m6A, while FTO and ALKBH5 have been identified as the main m6A erasers. Several protein families have been acknowledged as the m6A readers, including the YTH domain, hnRNP family including hnRNP-A2/B1, hnRNP-C, hnRNP-G, hnRNP-F, hnRNP-H1 and hnRNP-H2, as well as the KH domain, zf-CCHC domain, RBD, RRM, and zinc knuckle domain protein families.
The identified writers and erasers of the methylation modifications exhibit tissue-specific and delicate spatiotemporal expression patterns. More importantly, some writers, erasers, and / or the readers have been identified as the promising biomarkers that could be potentially translated to the clinical applications for therapy.
The levels and the landscapes of 5-mC, 5-hmC, 6mdA in the epigenome and m6A in the epitranscriptome are precisely and dynamically regulated by the fine-tuned orchestration of the writers, erasers, and readers in accordance with stages of the growth, development, and reproduction as naturally programmed during the lifespan. More interestingly, the emerging discoveries appreciate the link between aberrant modifications and pathogenesis of diseases, like cancers, neurodegenerative disorders, and so on.
Thus further investigation of the epigenetic mechanisms for regulation of biological process could accelerate dissection of the pathogenesis for the multiple human diseases caused by aberrant epigenomic and epitranscriptomic modifications.
This research topic will specifically focus on the research advances in the epigenomic and epitranscriptomic regulation of organs and systems development as well as the link between the epigenetic alteration and pathogenesis of human diseases.
Contributors are invited to submit original research articles as well as review articles, with focus on epigenomic and epitranscriptomic study. The collected manuscripts should address the functions of base modifications in epigenome and epitranscriptome, non-coding RNAs, as well as chromatin remodeling in the development of organs /systems and pathogenesis of human diseases. Potential topics include but not limited to:
 Identification of new epigenetic / epitranscriptomic marker(s), new writers / erasers / readers.
 Advancements in technology / bioinformatic methodology for analysis of the DNA and RNA modification markers.
 Application of high throughput sequencing in genome-wide mapping of epigenetic markers, and transcriptomes and proteomics in pathogenesis study of human diseases.
 Small molecule drug screening to identify the enhancers / repressors of the epigenetic modifications involved in embryogenesis, development of CNS, stem cells fate, and pathogenesis of diseases.
 Dynamic alteration of base modification markers and epigenetic landscapes during mammal development and in response to environment stimuli such as natural toxicity and artificial stress.
 Epigenomic and epitranscriptomic alteration in response to Coronal virus (including Cov-19) infection
 In vitro human organoids and in vivo animal models for epigenetic / epitranscriptomic study on development and diseases.
 Study on the link between aberrant modifications and disease using clinical patient samples
 Small RNAs and other non-coding RNAs such as miRNA, piRNA, LncRNA and

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Participating Journals

Impact

  • 70kTopic views
  • 47kArticle views
  • 20kArticle downloads
View impact